AUG 05, 2015 12:26 PM PDT

Making Muscles to Study Muscular Dystrophy

While skeletal muscle is abundant in the human body, it been difficult for researchers to derive muscle cells from precursor cells or culture in sufficient quantities to study them. New research, published Nature Biotechnology and reported in Bioscience Technology, describes how investigators from Harvard-affiliated Brigham and Women's Hospital (BWH) identified and mimicked important developmental cues. In so doing, they drove cells to grow into muscle fibers, "producing millimeter-long fibers capable of contracting in a dish and multiplying in large numbers." They hope that this procedure will "offer a better model for studying muscle diseases, such as muscular dystrophy, and for testing potential treatment options" (http://www.biosciencetechnology.com/news/2015/08/potential-treatment-muscular-dystrophy?et_cid=4712951&et_rid=45505806&type=cta).
Researchers from Harvard-affiliated Brigham and Women's Hospital (BWH) have grown differentiated muscle fibers (green) in the laboratory. The nuclei are blue.
According to the National Institute of Neurological Disorders and Stroke (NINDS), the muscular dystrophies (MD) include than 30 genetic diseases characterized by progressive weakness and degeneration of the skeletal muscles that control movement. MD disorders differ in terms of the distribution and extent of muscle weakness, age of onset, rate of progression and pattern of inheritance. Duchenne MD, the most common form, primarily affects boys. Caused by the absence of dystrophin, a protein involved in maintaining the integrity of muscle, it begins between 3 and 5 years of age and progresses rapidly. Most boys cannot walk by age 12 and later need a respirator for breathing. Girls in these families have a 50 percent chance of inheriting and passing the defective gene to their children. Boys with Becker MD have faulty or inadequate dystrophin. Facioscapulohumeral MD, which begins in the teenage years and progresses slowly, causes progressive weakness in muscles of the face, arms, legs, and around the shoulders and chest. Myotonic MD, the most common adult form, includes prolonged muscle spasms, cataracts, cardiac abnormalities and endocrine disturbances (http://www.ninds.nih.gov/disorders/md/md.htm).

Previous researchers have used genetic modification to create muscle cells in the lab, but the investigators from BWH and the Harvard Stem Cell Institute wanted to grow large numbers of muscle cells efficiently to use in clinical applications. According to corresponding author Olivier Pourquie of Harvard Medical School's Department of Genetics and BWH's Department of Pathology, "We took the hard route: We wanted to recapitulate all of the early stages of muscle cell development that happen in the body and re-create that in a dish in the lab. We analyzed each stage of early development, and generated cell lines that glowed green when they reached each stage. Going step by step, we managed to mimic each stage of development and coax cells toward muscle cell fate."

A combination of secreted factors important at early embryonic stages are also essential for stimulating differentiation, the specialization of stem cells into particular cell types. With the right recipe for differentiation, the team produced long, mature fibers in a dish, derived from mouse or human pluripotent stem cells. The researchers also cultured stem cells from the mouse model of Duchenne muscular dystrophy, viewing the branched pattern that dystrophin-deficient muscle fibers show in the body. They also produced more immature cells called satellite cells that, in turn, produced muscle fibers when grafted into a mouse model of Duchenne muscular dystrophy. In addition to developing a better model for Duchenne muscular dystrophy, the new protocol could be useful for studying other muscle diseases.

"This has been the missing piece: the ability to produce muscle cells in the lab could give us the ability to test out new treatments and tackle a spectrum of muscle diseases," said Pourquie.
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
AUG 28, 2018
Genetics & Genomics
AUG 28, 2018
A New Type of Cell is Discovered in the Human Brain
This cell type has never been observed in laboratory animals....
SEP 11, 2018
Immunology
SEP 11, 2018
Oops! I Broke My DNA
Innate Immune System, DNA Damage and Repair...
SEP 24, 2018
Videos
SEP 24, 2018
The Science of Being Transgender
Gender identity is an issue that some have trouble understanding. It’s not always about male or female, because gender can encompass more than those...
OCT 08, 2018
Videos
OCT 08, 2018
Harvesting Ancient DNA Samples
The story of an ancient insect that found itself trapped in amber is not a new one, but does it work?...
OCT 10, 2018
Genetics & Genomics
OCT 10, 2018
Using CRISPR in Utero to Treat Disease
Researchers have used a mouse model to show that it's possible to treat an illness before sickness occurs....
NOV 01, 2018
Genetics & Genomics
NOV 01, 2018
Genetic Risk Factor for Erectile Dysfunction is Discovered
Scientists have discovered a gene that is connected to erectile dysfunction for the first time. This work may help improve therapeutics for the problem....
Loading Comments...